Search
Mirum Pharmaceuticals Inc
MIRMAdd to Watchlist
93.180USD
-0.540-0.58%
Close 11-06 16:00（ET）
6.05BMarket Cap
LossP/E TTM
Today
-0.58%
5 Days
+8.68%
1 Month
+14.54%
6 Months
-13.05%
Year to Date
+17.96%
1 Year
+36.81%
Key Figures
95.100Open
95.680High
46.66KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
93.720Prev. Close
91.180Low
4.32MTurnover
LossP/E Static
-111.51P/B
0.00%Div Yield TTM
-101.04%ROA
130.00052wk High
0.06Volume Ratio
-87.94MNet Profit
64.93MShares
-13.5916EPS TTM
0.50Beta
-335.82%ROE
63.23252wk Low
4.80%Amplitude
81.06%Gross Margin
6.05BMarket Cap
-5.10Reward/Risk
3.08%Risk Rate
Mirum Pharmaceuticals Inc's Score
0.02vs previous score
Forecast8.86
Financial Health6.58
Technical4.63
Valuation Dimensions9.66
Institutional Confidence10.00
Risk Assessment6.48
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Mirum Pharmaceuticals Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Buy
Mirum Pharmaceuticals Inc Latest Earnings Call Transcripts
Mirum Pharmaceuticals (MIRM) Q3 2026 Earnings Call: Sales Reach $186M, Guidance Raised
Mirum Pharmaceuticals Q3 2026 net product sales reached $186 million as LIVMARLI drove growth, prompting higher full-year guidance of $715 million-$720 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.62/-0.49
Revenue / Forecast
185.72M/178.08M
Mirum Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolMIRM
Number of employees322
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Frazier Life Sciences Management, L.P. | 12.59% |
| Janus Henderson Investors | 9.95% |
| BlackRock Institutional Trust Company, N.A. | 5.13% |
| Vanguard Capital Management, LLC | 3.96% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 35.04% |
| Investment Advisor | 34.03% |
| Hedge Fund | 16.35% |
| Private Equity | 13.71% |
Related Instruments
+4.28%
+2.13%
+0.68%
+1.38%
+0.70%
+1.59%
+1.04%
+1.46%
+2.65%
-0.54%
+0.69%
0.00%
-0.14%
+2.30%
+5.83%
+2.40%
+1.73%
+0.33%
+0.95%
+3.78%
FAQs
What is the current price of Mirum Pharmaceuticals Inc (MIRM)?
The current price of Mirum Pharmaceuticals Inc (MIRM) is 93.18.
What is the symbol of Mirum Pharmaceuticals Inc?
The ticker symbol of Mirum Pharmaceuticals Inc is MIRM.
What is the 52-week high of Mirum Pharmaceuticals Inc?
The 52-week high of Mirum Pharmaceuticals Inc is 130.00.
What is the 52-week low of Mirum Pharmaceuticals Inc?
The 52-week low of Mirum Pharmaceuticals Inc is 63.23.
What is the market capitalization of Mirum Pharmaceuticals Inc?
The market capitalization of Mirum Pharmaceuticals Inc is 6.05B.
Is Mirum Pharmaceuticals Inc (MIRM) currently rated as Buy, Hold, or Sell?
According to analysts, Mirum Pharmaceuticals Inc (MIRM) has an overall rating of Buy, with a price target of 155.85.
What is the Earnings Per Share (EPS TTM) of Mirum Pharmaceuticals Inc (MIRM)?
The Earnings Per Share (EPS TTM) of Mirum Pharmaceuticals Inc (MIRM) is -13.59.